Li N, Chen H L, Li M J, Luo G X, Yuan Z Q
State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Burn Research, the First Affiliated Hospital of Army Medical University (the Third Military Medical University), Chongqing 400038, China.
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2022 Jan 20;38(1):29-37. doi: 10.3760/cma.j.cn501120-20201201-00511.
To explore the application effects of bundle nursing of citric acid extracorporeal anticoagulation on continuous renal replacement therapy (CRRT) of severe burn patients. A non-randomized controlled study was conducted. Forty-six patients who met the inclusion criteria and received regular nursing of citric acid extracorporeal anticoagulation during CRRT in the First Affiliated Hospital of Army Medical University (the Third Military Medical University) from January to December 2017 were included in regular nursing group (30 males and 16 females, aged 42.0 (38.7,47.0) years, with 201 times of CRRT performed), and 48 patients who met the inclusion criteria and received bundle nursing of citric acid extracorporeal anticoagulation during CRRT in the same hospital from January to December 2018 were included in bundle nursing group (32 males and 16 females, aged 41.0 (36.0,46.0) years, with 164 times of CRRT performed). The clinical data of all the patients in the two groups were recorded, including the length of intensive care unit (ICU) stay, total cost of treatment in ICU, cost of CRRT, unplanned ending of treatment, ending of treatment due to operation (with the rates of unplanned ending of treatment and ending of treatment due to operation calculated), times of disposable hemodialysis filter and supporting pipeline filter (hereinafter referred to as filter) with use time>24 h, times of CRRT, and lifetime of filter. For the patients in both groups who continuously received CRRT for 3 days or more from the first treatment, the prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), total calcium, ionic calcium (with the difference of total calcium or ionic calcium between before and after treatment calculated), creatinine, urea, β microglobulin, cystatin C, platelet count, mean arterial pressure, pH value, oxygenation index, bicarbonate radical, and lactic acid levels before the first treatment (hereinafter referred to as before treatment) and 3 days after the first treatment (hereinafter referred to as after 3 days of treatment). The treatment-related complications of all patients in the two groups were recorded during hospitalization. Data were statistically analyzed with independent sample test, Mann-Whitney test, and chi-square test. Compared with those in regular nursing group, the length of ICU stay was significantly shortened (=-4.71, <0.01), the total cost of treatment in ICU was significantly reduced (=-1.39, <0.01), the cost of CRRT had no significant change (>0.05), the rates of unplanned ending of treatment and ending of treatment due to operation were both significantly decreased (with values of 12.20 and 17.83, respectively, <0.01), the times of filter service time>24 h was increased significantly (=-5.93, <0.01), the times of CRRT were significantly reduced (=-4.75, <0.01), and the filter service life was significantly prolonged (=-9.24, <0.01) among patients in bundle nursing group. Thirty-one patients in bundle nursing group and 28 patients in regular nursing group continuously received CRRT for 3 days or more from the first treatment. Before treatment, PT, APTT, and INR of patients in bundle nursing group were 24.10 (16.08, 39.20) s, 38.81 (32.32, 45.50) s, and 1.17 (1.12, 1.19), respectively, similar to 31.75 (22.99, 40.96) s, 41.82 (35.05, 48.06) s, and 1.15 (1.11, 1.19) of patients in regular nursing group (>0.05); the levels of total calcium and ionic calcium of patients in the two groups were similar (>0.05). After 3 days of treatment, PT, APTT, and INR of patients in bundle nursing group and regular nursing group were 29.06 (20.11, 39.46) s, 35.25 (30.06, 40.28) s, 1.13 (1.09, 1.17) and 36.51 (26.64, 42.92) s, 39.89 (34.81, 46.62) s, 1.14 (1.10, 1.18), respectively, similar to those before treatment (>0.05); the level of ionic calcium of patients in regular nursing group was significantly higher than that before treatment (=-2.08, <0.05); the levels of total calcium and ionic calcium of patients in bundle nursing group were both significantly higher than those before treatment (with values of -3.55 and -3.69, respectively, <0.01); compared with those in regular nursing group, APTT of patients was significantly shorter (=-2.29, <0.05), while the total calcium level of patients was significantly higher in bundle nursing group (=-2.26, <0.05). The difference of total calcium between before and after treatment of patients in bundle nursing group was significantly higher than that in regular nursing group (=-3.15, <0.01). The differences of ionic calcium between before and after treatment of patients in the two groups were similar (>0.05). Before treatment, the level of β microglobulin of patients in bundle nursing group was significantly higher than that in regular nursing group (=-2.84, <0.01), the platelet count of patients in bundle nursing group was significantly lower than that in regular nursing group (=-2.44, <0.05), while the levels of creatinine, urea, cystatin C, mean arterial pressure, pH value, oxygenation index, bicarbonate radical, and lactic acid of patients in the two groups were similar (>0.05). After 3 days of treatment, the levels of creatinine, urea, β microglobulin, cystatin C, pH value, bicarbonate radical, and lactic acid of patients were all significantly lower than those before treatment (with values of -2.10, -2.90, -3.11, -2.02, -2.34, -2.63, and -2.84, respectively, <0.05 or <0.01), while the levels of platelet count, oxygenation index, and mean arterial pressure of patients were all significantly higher than those before treatment in bundle nursing group (with values of -6.65 and -2.40, respectively, =-9.97, <0.05 or <0.01); the levels of creatinine, urea, β microglobulin, cystatin C, platelet count, pH value, bicarbonate radical, and lactic acid of patients were all significantly lower than those before treatment (with values of -5.32, -2.31, -2.41, -2.21, -3.68, -2.93, -2.20, and -2.31, respectively, <0.05 or <0.01), while the oxygenation index and mean arterial pressure of patients were both significantly higher than those before treatment in regular nursing group (=-5.59, =-7.74, <0.01). After 3 days of treatment, compared with those in regular nursing group, the levels of creatinine, cystatin C, platelet count, oxygenation index, bicarbonate radical, and mean arterial pressure of patients were all significantly higher (with values of -2.93, -1.99, -6.39, -2.09, and -2.52, respectively, =-3.28, <0.05 or <0.01), while the levels of urea, β microglobulin, pH value, and lactic acid of patients were all significantly lower (with values of -3.87, -2.58, -4.24, and -2.75, respectively, <0.05 or <0.01) in bundle nursing group. During hospitalization, there were no treatment-related bleeding events or hypernatremia related to citric acid treatment of patients in the two groups. The ratio of total calcium to ionic calcium in one patient in bundle nursing group was >2.5, but there was no manifestation of citric acid accumulation poisoning; 1 patient had hypoionic calcemia, and 1 patient had severe metabolic alkalosis. Five patients had hypoionic calcemia and 2 patients had severe metabolic alkalosis in regular nursing group. The implementation of bundle nursing of citric acid extracorporeal anticoagulation during CRRT for severe burn patients shortens the length of ICU stay, reduces the total cost of treatment in ICU and the occurrence of treatment-related complications, relieves the economic burden of patients, and improves the continuity and quality of treatment.
探讨枸橼酸体外抗凝集束化护理在重度烧伤患者连续性肾脏替代治疗(CRRT)中的应用效果。进行一项非随机对照研究。选取2017年1月至12月在陆军军医大学第一附属医院(第三军医大学)行CRRT期间符合纳入标准并接受枸橼酸体外抗凝常规护理的46例患者作为常规护理组(男30例,女16例,年龄42.0(38.7,47.0)岁,行CRRT 201次),选取2018年1月至12月在同一医院行CRRT期间符合纳入标准并接受枸橼酸体外抗凝集束化护理的48例患者作为集束化护理组(男32例,女16例,年龄41.0(36.0,46.0)岁,行CRRT 164次)。记录两组所有患者的临床资料,包括重症监护病房(ICU)住院时间、ICU治疗总费用、CRRT费用、治疗计划外结束、因手术导致的治疗结束情况(计算治疗计划外结束率和因手术导致的治疗结束率)、使用时间>24 h的一次性血液透析滤器及配套管路滤器(以下简称滤器)次数、CRRT次数及滤器使用寿命。对两组中从首次治疗开始连续接受CRRT 3天及以上的患者,检测首次治疗前(以下简称治疗前)及首次治疗后3天(以下简称治疗3天后)的凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、国际标准化比值(INR)、总钙、离子钙(计算治疗前后总钙或离子钙的差值)、肌酐、尿素、β微球蛋白、胱抑素C、血小板计数、平均动脉压、pH值、氧合指数、碳酸氢根及乳酸水平。记录两组所有患者住院期间与治疗相关的并发症。采用独立样本t检验、Mann-Whitney U检验及卡方检验进行统计学分析。与常规护理组相比,集束化护理组患者的ICU住院时间显著缩短(t=-4.71,P<0.01),ICU治疗总费用显著降低(t=-1.39,P<0.01),CRRT费用无显著变化(P>0.05),治疗计划外结束率和因手术导致的治疗结束率均显著降低(卡方值分别为12.20和17.83,P<0.01),滤器使用时间>24 h的次数显著增加(t=-5.93,P<0.01),CRRT次数显著减少(t=-4.75,P<0.01),滤器使用寿命显著延长(t=-9.24,P<0.01)。集束化护理组31例患者和常规护理组28例患者从首次治疗开始连续接受CRRT 3天及以上。治疗前,集束化护理组患者的PT、APTT及INR分别为24.10(16.08,39.20)s、38.81(32.32,45.50)s及1.17(1.12,1.19),与常规护理组患者的31.75(22.99,40.96)s、41.82(35.05,48.06)s及1.15(1.11,1.19)相似(P>0.05);两组患者的总钙和离子钙水平相似(P>0.05)。治疗3天后,集束化护理组和常规护理组患者的PT、APTT及INR分别为29.06(20.11,39.46)s、35.25(30.06,40.28)s、1.13(1.09,1.17)及36.51(26.64,42.92)s、39.89(34.81,46.62)s、1.14(1.10,1.18),与治疗前相似(P>0.05);常规护理组患者的离子钙水平显著高于治疗前(t=-2.08,P<0.05);集束化护理组患者的总钙和离子钙水平均显著高于治疗前(t值分别为-3.55和-3.69,P<0.01);与常规护理组相比,集束化护理组患者的APTT显著缩短(t=-2.29,P<0.05),而总钙水平显著升高(t=-2.26,P<0.05)。集束化护理组患者治疗前后总钙差值显著高于常规护理组(t=-3.15,P<0.01)。两组患者治疗前后离子钙差值相似(P>0.05)。治疗前,集束化护理组患者的β微球蛋白水平显著高于常规护理组(t=-2.84,P<0.01),集束化护理组患者的血小板计数显著低于常规护理组(t=-2.44,P<0.05),而两组患者的肌酐、尿素、胱抑素C、平均动脉压、pH值、氧合指数、碳酸氢根及乳酸水平相似(P>0.05)。治疗3天后,两组患者的肌酐、尿素、β微球蛋白、胱抑素C、pH值、碳酸氢根及乳酸水平均显著低于治疗前(t值分别为-2.10、-2.90、-3.11、-2.02、-2.34、-2.63及-2.84,P<0.05或P<0.01),而集束化护理组患者的血小板计数、氧合指数及平均动脉压均显著高于治疗前(t值分别为-6.65和-2.40,t=-9.97,P<0.05或P<0.01);常规护理组患者的肌酐、尿素、β微球蛋白、胱抑素C、血小板计数、pH值、碳酸氢根及乳酸水平均显著低于治疗前(t值分别为-5.32、-2.31、-2.41、-2.21、-3.68、-2.93、-2.20及-2.31,P<0.05或P<0.01),而常规护理组患者的氧合指数和平均动脉压均显著高于治疗前(t=-5.59,t=-7.74,P<0.01)。治疗3天后,与常规护理组相比,集束化护理组患者的肌酐、胱抑素C、血小板计数、氧合指数、碳酸氢根及平均动脉压均显著升高(t值分别为-2.93、-1.99、-6.39、-2.09及-2.52,t=-3.28,P<0.05或P<